Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1970 Dec;40(4):836–846. doi: 10.1111/j.1476-5381.1970.tb10659.x

Effects of intraventricular 2,4,5-trihydroxyphenylethylamine (6-hydroxydopamine) on rat behaviour and brain catecholamine metabolism

R Laverty, K M Taylor
PMCID: PMC1702926  PMID: 5495179

Abstract

1. 6-Hydroxydopamine (200 μg injected intraventricularly) caused depletion of noradrenaline from all regions of rat brain within 2 h after injection but depletion of dopamine in the brain was observed only from 2 days after injection. Both catecholamines remained depleted for more than 32 days.

2. Rats treated with intraventricular 6-hydroxydopamine were sedated and lethargic, with reduced spontaneous and exploratory activity, for periods of up to 8 days after injection. Conditioned avoidance responding was abolished or reduced for a similar period.

3. Intraventricular 6-hydroxydopamine caused a prolonged reduction in the amount of labelled catecholamines in store 4 h following an intraventricular injection of 3H-dopamine. During the first 6 h after 6-hydroxydopamine injection, there was a marked increase in neutral and acid metabolites from the labelled catecholamines.

4. A comparison of the behavioural and biochemical effects of intraventricular 6-hydroxydopamine and reserpine suggests that both drugs affect catecholamine storage mechanisms but by different mechanisms. It was not possible from these experiments to correlate behavioural changes with either catecholamine storage or metabolism.

Full text

PDF
836

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. COOK L., WEIDLEY E. Behavioral effects of some psychopharmacological agents. Ann N Y Acad Sci. 1957 Mar 14;66(3):740–752. doi: 10.1111/j.1749-6632.1957.tb40763.x. [DOI] [PubMed] [Google Scholar]
  2. LAVERTY R., SHARMAN D. F., VOGT M. ACTION OF 2, 4, 5-TRIHYDROXYPHENYLETHYLAMINE ON THE STORAGE AND RELEASE OF NORADRENALINE. Br J Pharmacol Chemother. 1965 Apr;24:549–560. doi: 10.1111/j.1476-5381.1965.tb01745.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Laverty R., Taylor K. M. The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique. Anal Biochem. 1968 Feb;22(2):269–279. doi: 10.1016/0003-2697(68)90316-3. [DOI] [PubMed] [Google Scholar]
  4. Malmfors T., Sachs C. Degeneration of adrenergic nerves produced by 6-hydroxydopamine. Eur J Pharmacol. 1968 Apr;3(1):89–92. doi: 10.1016/0014-2999(68)90056-3. [DOI] [PubMed] [Google Scholar]
  5. PORTER C. C., TOTARO J. A., STONE C. A. Effect of 6-hydroxydopamine and some other compounds on the concentration of norepinephrine in the hearts of mice. J Pharmacol Exp Ther. 1963 Jun;140:308–316. [PubMed] [Google Scholar]
  6. Phelan E. L. The New Zealand strain of rats with genetic hypertension. N Z Med J. 1968 Mar;67(429):334–344. [PubMed] [Google Scholar]
  7. STEINBERG H., RUSHTON R., TINSON C. Modification of the effects of an amphetamine-barbiturate mixture by the past experience of rats. Nature. 1961 Nov 11;192:533–535. doi: 10.1038/192533a0. [DOI] [PubMed] [Google Scholar]
  8. Schildkraut J. J., Kety S. S. Biogenic amines and emotion. Science. 1967 Apr 7;156(3771):21–37. doi: 10.1126/science.156.3771.21. [DOI] [PubMed] [Google Scholar]
  9. Taylor K. M., Laverty R. The metabolism of tritiated dopamine in regions of the rat brain in vivo. I. The separation of catecholamines and their metabolites. J Neurochem. 1969 Sep;16(9):1361–1366. doi: 10.1111/j.1471-4159.1969.tb05987.x. [DOI] [PubMed] [Google Scholar]
  10. Taylor K. M., Laverty R. The metabolism of tritiated dopamine in regions of the rat brain in vivo. II. The significance of the neutral metabolites of catecholamines. J Neurochem. 1969 Sep;16(9):1367–1376. doi: 10.1111/j.1471-4159.1969.tb05988.x. [DOI] [PubMed] [Google Scholar]
  11. Tranzer J. P., Thoenen H. An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine. Experientia. 1968 Feb 15;24(2):155–156. doi: 10.1007/BF02146956. [DOI] [PubMed] [Google Scholar]
  12. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol. 1968 Dec;5(1):107–110. doi: 10.1016/0014-2999(68)90164-7. [DOI] [PubMed] [Google Scholar]
  13. Uretsky N. J., Iversen L. L. Effects of 6-hydroxydopamine on noradrenaline-containing neurones in the rat brain. Nature. 1969 Feb 8;221(5180):557–559. doi: 10.1038/221557a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES